Hedge Fund Sees 20 Percent Returns on Picks From Nobel Prize Winners


Thanks to the advice from a range of professors, Swedish hedge fund Rhenman Healthcare Equity L/S has delivered an average annual return of 21 percent since it started in 2009. Asking clinical expertise before investing in complex products is a must for Henrik Rhenman, who manages the 460 million-euro fund.



from Biotech News